MedPath

A clinical trial to evaluate the efficacy of shwadanshtradi ghana vati as compare to tablet cefixime in the management of garbhini mutrakrichhra (urinary tract infection during pregnanacy)

Phase 3
Conditions
Health Condition 1: N342- Other urethritisHealth Condition 2: N390- Urinary tract infection, site notspecified
Registration Number
CTRI/2023/05/052987
Lead Sponsor
All india institute of ayurveda , New delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Pregnant women (Primigravida or Multi gravida) with age of 20 to 35 years who are

attending AIIA Hospital for Ante natal care with gestational age from 16 weeks to

36 weeks with signs & symptoms of Mutrakricchra (UTI during Pregnancy) - Sadah

Mutrata (Burning Micturition), Saruja Mutrata (Painful Micturition), Muhur muhur mutrata (Frequency Micturition), Adho udar shola (Lower abdominal pain).

• Pregnant women with asymptomatic Bacteriurea. (Patients those who are not having

any signs & symptoms of UTI, but there Lab reports of Urine analysis and Urine

culture are suggestive of UTI.)

• Pregnant women willing for trial.

Exclusion Criteria

All non-pregnant women with UTI.

• Postpartum UTI.

• Pre-existing congenital renal tract anomalies.

• Pregnant Women with chronic renal disorders, Polycystic kidneys, Hydronephrosis,

Impaired renal function.

• Pregnant women who need hospitalization for urinary problem with uterine

discomfort with urine analysis and urine culture report suggestive of UTI.

• Malignancy of Urinary Tract.

• Immuno-compromised patients.

• Pregnant women with severe anemia Hb < 7 gm/dl.

• Pregnancy complicated with other medical disorders.

• Any complication in pregnancy like Polyhydroamnios, Placental abnormalities.

• Pregnancy induced hypertension.

• Gestational Diabetes Mellitus.

• Pregnancy with thyroid dysfunction, High Risk Pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relief in signs and Symptoms in Garbhini MutrakricchraTimepoint: patient will be assessed on 5th, 10th day and 17th day based on sign and symptomes of mutrakricchra
Secondary Outcome Measures
NameTimeMethod
To evaluate the efficacy of Shwadanshtradi ghana vati by Urine (Random & <br/ ><br>Microscopic) examination and Urine culture & sensitivity reportTimepoint: 1 to 5 days
© Copyright 2025. All Rights Reserved by MedPath